Παρακολούθηση
Heinz-Josef Lenz
Heinz-Josef Lenz
University of Southern Califfornia
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα usc.edu
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
13191*2021
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
A Grothey, E Van Cutsem, A Sobrero, S Siena, A Falcone, M Ychou, ...
The Lancet 381 (9863), 303-312, 2013
30692013
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
MJ Overman, R McDermott, JL Leach, S Lonardi, HJ Lenz, MA Morse, ...
The lancet oncology 18 (9), 1182-1191, 2017
25382017
Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer
MJ Overman, S Lonardi, KYM Wong, HJ Lenz, F Gelsomino, M Aglietta, ...
Journal of clinical oncology 36 (8), 773-779, 2018
19042018
Randomized trial of TAS-102 for refractory metastatic colorectal cancer
RJ Mayer, E Van Cutsem, A Falcone, T Yoshino, R Garcia-Carbonero, ...
New England Journal of Medicine 372 (20), 1909-1919, 2015
13992015
EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer
AF Sobrero, J Maurel, L Fehrenbacher, W Scheithauer, YA Abubakr, ...
Journal of clinical oncology 26 (14), 2311-2319, 2008
11932008
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase
D Salonga, KD Danenberg, M Johnson, R Metzger, S Groshen, ...
Clinical Cancer Research 6 (4), 1322-1327, 2000
11132000
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation–a target for novel cancer therapy
R Tokunaga, WU Zhang, M Naseem, A Puccini, MD Berger, S Soni, ...
Cancer treatment reviews 63, 40-47, 2018
10262018
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and RAS Mutations in Colorectal Cancer
E Van Cutsem, HJ Lenz, CH Köhne, V Heinemann, S Tejpar, I Melezínek, ...
Journal of clinical oncology 33 (7), 692-700, 2015
9212015
Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors
PG Johnston, HJ Lenz, CG Leichman, KD Danenberg, CJ Allegra, ...
Cancer research 55 (7), 1407-1412, 1995
9021995
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six …
D Arnold, B Lueza, JY Douillard, M Peeters, HJ Lenz, A Venook, ...
Annals of oncology 28 (8), 1713-1729, 2017
8772017
ERCC1 and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil Chemotherapy
Y Shirota, J Stoehlmacher, J Brabender, YP Xiong, H Uetake, ...
Journal of Clinical Oncology 19 (23), 4298-4304, 2001
8572001
Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer: a …
AP Venook, D Niedzwiecki, HJ Lenz, F Innocenti, B Fruth, JA Meyerhardt, ...
Jama 317 (23), 2392-2401, 2017
8282017
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer
MM Pomerantz, N Ahmadiyeh, L Jia, P Herman, MP Verzi, ...
Nature genetics 41 (8), 882-884, 2009
7862009
Prognostic and predictive relevance of primary tumor location in patients with RAS wild-type metastatic colorectal cancer: retrospective analyses of the CRYSTAL and FIRE-3 trials
S Tejpar, S Stintzing, F Ciardiello, J Tabernero, E Van Cutsem, F Beier, ...
JAMA oncology 3 (2), 194-201, 2017
7762017
Activity of sunitinib in patients with advanced neuroendocrine tumors
MH Kulke, HJ Lenz, NJ Meropol, J Posey, DP Ryan, J Picus, E Bergsland, ...
Journal of Clinical Oncology 26 (20), 3403-3410, 2008
7542008
Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy
ST Pullarkat, J Stoehlmacher, V Ghaderi, YP Xiong, SA Ingles, A Sherrod, ...
The pharmacogenomics journal 1 (1), 65-70, 2001
7302001
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil …
R Metzger, CG Leichman, KD Danenberg, PV Danenberg, HJ Lenz, ...
Journal of Clinical Oncology 16 (1), 309-316, 1998
6881998
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret …
AA Garcia, H Hirte, G Fleming, D Yang, DD Tsao-Wei, L Roman, ...
Journal of Clinical Oncology 26 (1), 76-82, 2008
6792008
CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts …
AP Venook, D Niedzwiecki, HJ Lenz, F Innocenti, MR Mahoney, BH O'Neil, ...
Journal of Clinical Oncology 32 (15_suppl), LBA3-LBA3, 2014
6452014
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20